Related references
Note: Only part of the references are listed.Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer
James Yarmolinsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis
Azam Majidi et al.
GYNECOLOGIC ONCOLOGY (2020)
Improving the Prescribing Gap For Guideline Recommended Medications Post Myocardial Infarction
Ben Wilkins et al.
HEART LUNG AND CIRCULATION (2019)
Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells
Andy Goebel et al.
CELL DEATH & DISEASE (2019)
Use of Statin Medications Following Diagnosis in Relation to Survival among Women with Ovarian Cancer
Barbara N. Harding et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
Elina Urpilainen et al.
BMC CANCER (2018)
Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer
Tilley Jenkins Vogel et al.
GYNECOLOGIC ONCOLOGY (2017)
Statin use and mortality among ovarian cancer patients: A population-based cohort study
Freija Verdoodt et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Appropriate Reconciliation of Cardiovascular Medications After Elective Surgery and Postdischarge Acute Hospital and Ambulatory Visits
Jonathan S. Lee et al.
JOURNAL OF HOSPITAL MEDICINE (2017)
Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis
Janick Weberpals et al.
CANCER TREATMENT REVIEWS (2016)
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
Miguel A. Hernan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis
Peter C. Austin
STATISTICS IN MEDICINE (2016)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Threats to Validity of Nonrandomized Studies of Postdiagnosis Exposures on Cancer Recurrence and Survival
Jessica Chubak et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Patrizia Gazzerro et al.
PHARMACOLOGICAL REVIEWS (2012)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Weight Trimming and Propensity Score Weighting
Brian K. Lee et al.
PLOS ONE (2011)
Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase
S. Kato et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect Modification
Mark Lunt et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Observational Studies Analyzed Like Randomized Experiments An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease
Miguel A. Hernan et al.
EPIDEMIOLOGY (2008)
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Chao-Yung Wang et al.
TRENDS IN MOLECULAR MEDICINE (2008)
A comparison of propensity score methods: A case-study estimating the effectiveness of post-AMI statin use
PC Austin et al.
STATISTICS IN MEDICINE (2006)
Variable selection for propensity score models
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)